[go: up one dir, main page]

NO883594L - Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. - Google Patents

Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Info

Publication number
NO883594L
NO883594L NO88883594A NO883594A NO883594L NO 883594 L NO883594 L NO 883594L NO 88883594 A NO88883594 A NO 88883594A NO 883594 A NO883594 A NO 883594A NO 883594 L NO883594 L NO 883594L
Authority
NO
Norway
Prior art keywords
various
procedure
preparation
rna preparations
double wired
Prior art date
Application number
NO88883594A
Other languages
English (en)
Other versions
NO883594D0 (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO883594D0 publication Critical patent/NO883594D0/no
Publication of NO883594L publication Critical patent/NO883594L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO88883594A 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. NO883594L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
NO883594D0 NO883594D0 (no) 1988-08-12
NO883594L true NO883594L (no) 1989-02-13

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883594A NO883594L (no) 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Country Status (19)

Country Link
EP (1) EP0308066B1 (no)
JP (1) JPH01131119A (no)
KR (1) KR0131879B1 (no)
CN (1) CN1050995C (no)
AT (1) ATE132041T1 (no)
AU (3) AU2053588A (no)
CA (1) CA1327002C (no)
DE (1) DE3854829T2 (no)
DK (1) DK449888A (no)
FI (1) FI883763A7 (no)
HU (1) HUT47854A (no)
IE (1) IE72103B1 (no)
IL (1) IL87413A0 (no)
NO (1) NO883594L (no)
NZ (1) NZ225799A (no)
OA (1) OA08901A (no)
PT (1) PT88266B (no)
RU (1) RU1834663C (no)
ZA (1) ZA885967B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122402T1 (de) * 1987-09-04 1995-05-15 Hem Pharma Corp Diagnose von mangelzuständen doppelsträngiger rns.
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
JPH02504429A (ja) * 1988-05-23 1990-12-13 ガイ,ステファン リウマチ様関節炎の診断と治療
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用dsRNA
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
JP3150967B2 (ja) * 1989-10-11 2001-03-26 エイチイーエム リサーチ,インコーポレイティド 二本鎖rnaによる損傷に続くショックからの保護
EP0495831B1 (en) * 1989-10-16 1997-01-15 Hem Pharmaceuticals Corp. Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
JP2002514999A (ja) * 1991-09-26 2002-05-21 ヘム・ファーマスーティカル・コーポレーション dsRNAを用いてIL−1を中和する方法
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CA2323726C (en) 1998-03-20 2005-02-08 Benitec Australia Ltd. Control of gene expression
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
WO2003087368A2 (en) * 2002-04-18 2003-10-23 Lynkeus Bio Tech Gmbh Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
WO2004022075A1 (en) 2002-09-04 2004-03-18 Novartis Ag Treatment of neurological disorders by dsrna adminitration
JP2010520284A (ja) * 2007-03-05 2010-06-10 ユタ ステイト ユニバーシティ Toll様受容体3(TLR3)の限定アゴニスト
CA2745832A1 (en) 2008-12-04 2010-06-10 Opko Ophthalmics, Llc Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
FI883763A0 (fi) 1988-08-12
NZ225799A (en) 1991-04-26
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31
IE882399L (en) 1989-02-12
FI883763L (fi) 1989-02-13
CN1032740A (zh) 1989-05-10
EP0308066A3 (en) 1991-01-16
KR890003402A (ko) 1989-04-14
EP0308066B1 (en) 1995-12-27
HUT47854A (en) 1989-04-28
DK449888D0 (da) 1988-08-11
ZA885967B (en) 1989-07-26
ATE132041T1 (de) 1996-01-15
AU2053588A (en) 1989-04-20
AU1001595A (en) 1995-02-23
DE3854829T2 (de) 1996-08-14
IL87413A0 (en) 1989-01-31
CN1050995C (zh) 2000-04-05
AU1736792A (en) 1992-07-30
PT88266A (pt) 1989-06-30
JPH01131119A (ja) 1989-05-24
EP0308066A2 (en) 1989-03-22
PT88266B (pt) 1995-05-04
IE72103B1 (en) 1997-03-12
FI883763A7 (fi) 1989-02-13
DE3854829D1 (de) 1996-02-08
DK449888A (da) 1989-02-13
CA1327002C (en) 1994-02-15
NO883594D0 (no) 1988-08-12
RU1834663C (ru) 1993-08-15

Similar Documents

Publication Publication Date Title
NO883594D0 (no) Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.
EP0400958A3 (en) Live vaccines
EP1340744A3 (en) Hiv protease inhibitors
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DK0652208T3 (da) Phenylalkan(en)syrer
IE45812L (en) Treatment of infections with pseudomonic acid
JPS5519239A (en) Interferon-producing attractant
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
WHEELER et al. Influence of specific antibody on herpes simplex infections in tissue culture
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
Vignaux et al. Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts
DE69031569D1 (de) Podophyllotoxinzubereitung enthaltend triglyceride
Wargo Interaction of stress and secondary organisms in decline of forest trees.
ATE123625T1 (de) Herstellung von erhöhten biokontrollwirkstoffen.
JPS5636483A (en) 66imidazolyll33hydrazinoopyridazine* its manufacture and medicine containing it
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
JPS5492680A (en) Novel microorganism
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.
KR870009018A (ko) 단순 포진에 대한 왁진